Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Oncotargets and Therapy|March 11, 2017
Evidence from a meta-analysis: is nivolumabneurotoxic in cancer patients?Xiangyi Kong, Yanguo KongJournal of Cellular and Molecular Medicine|September 24, 2017
Roles and expression profiles of long non-coding RNAs in triple-negative breast cancersXiangyi Kong, Wenyue Liu, Yanguo KongZhonghua Yi Xue Za Zhi|July 23, 2002
[Detection of serum epidermal growth factor receptor in the diagnosis of proliferation of pituitary adenomas]Yanguo Kong, Zuyuan Ren, Changbao Su, et al.Medicine|January 26, 2017
Malignant adenohypophysis spindle cell oncocytoma with repeating recurrences and a high Ki-67 indexXiangyi Kong, Dongmei Li, Yanguo Kong, et al.Ebiomedicine|December 23, 2017
Automatic Detection of Acromegaly From Facial Photographs Using Machine Learning MethodsXiangyi Kong, Shun Gong, Lijuan Su, et al.Oncotarget|November 16, 2017
Association of opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with nicotine dependenceXiangyi Kong, Hao Deng, Theodore Alston, et al.Journal of Cellular and Molecular Medicine|August 12, 2017
Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomasXiangyi Kong, Shun Gong, Lijuan Su, et al.Oncotarget|December 22, 2017
Neuroprotective effects of allicin on ischemia-reperfusion brain injuryXiangyi Kong, Shun Gong, Lijuan Su, et al.BMC Medical Genetics|October 27, 2017
Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studiesXiangyi Kong, Hao Deng, Shun Gong, et al.American Journal of Translational Research|October 17, 2018
Opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) and postoperative nausea and vomitingYanguo Kong, Tao Yan, Shun Gong, et al.Pageof 2